{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:47:18Z","timestamp":1766508438406,"version":"3.48.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["74833"],"award-info":[{"award-number":["74833"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06385-6","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:35:10Z","timestamp":1766496910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles-derived non-coding RNA in leukemias and pre-leukemic syndromes: a systematic review"],"prefix":"10.1007","volume":"152","author":[{"given":"Narjes","family":"Seddighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malihe","family":"Najafpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Riyahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Mahmoudzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"6385_CR1","unstructured":"Adelaide Tu (2020) Checklist for cohort studies: critical appraisal tools for use in JBI systematic reviews. JBI Glob"},{"key":"6385_CR2","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1182\/blood-2023-187856","volume":"142","author":"ZY An","year":"2023","unstructured":"An ZY, Fu H, He Y, Zhu X, Huang QS, Wu J et al (2023) Projected global trends in hematological malignancies: incidence, mortality, and disability-adjusted life years from 2020 to 2030. Blood 142:3810","journal-title":"Blood"},{"issue":"21","key":"6385_CR3","doi-asserted-by":"publisher","first-page":"e151513","DOI":"10.1172\/jci.insight.151513","volume":"6","author":"L Babin","year":"2021","unstructured":"Babin L, Andraos E, Fuchs S, Pyronnet S, Brunet E, Meggetto F (2021) From circRNAs to fusion circRNAs in hematological malignancies. JCI Insight 6(21):e151513","journal-title":"JCI Insight"},{"issue":"8","key":"6385_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/CAD.0000000000001068","volume":"32","author":"J Bi","year":"2021","unstructured":"Bi J, Pu Y, Yu X (2021) Exosomal circ_0004136 enhances the progression of pediatric acute myeloid leukemia depending on the regulation of miR-570-3p\/TSPAN3 axis. Anticancer Drugs 32(8):802\u2013811","journal-title":"Anticancer Drugs"},{"issue":"4","key":"6385_CR5","doi-asserted-by":"publisher","first-page":"e95240","DOI":"10.1371\/journal.pone.0095240","volume":"9","author":"W Chen","year":"2014","unstructured":"Chen W, Liu X, Lv M, Chen L, Zhao J, Zhong S et al (2014) Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS ONE 9(4):e95240","journal-title":"PLoS ONE"},{"issue":"3","key":"6385_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3892\/etm.2023.11825","volume":"25","author":"L Chen","year":"2023","unstructured":"Chen L, Xie T, Wei B, Di DL (2023) Tumour-derived exosomes and their emerging roles in leukaemia. Exp Ther Med 25(3):126","journal-title":"Exp Ther Med"},{"issue":"1","key":"6385_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/cells10010101","volume":"10","author":"CC Damanti","year":"2021","unstructured":"Damanti CC, Gaffo E, Lovisa F, Garbin A, Di Battista P, Gallingani I et al (2021) MiR-26a-5p as a reference to normalize microRNA qRT-PCR levels in plasma exosomes of pediatric hematological malignancies. Cells 10(1):101","journal-title":"Cells"},{"issue":"1","key":"6385_CR8","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1038\/s41598-025-87857-0","volume":"15","author":"NR Dashti","year":"2025","unstructured":"Dashti NR, Fadavi D, Rezaei R, Rahgozar S, Moafi A (2025) Circulating lncRNA HOTAIR is a biomarker for pediatric acute lymphoblastic leukemia and mediator of miR-326 exosomal export. Sci Rep 15(1):4901","journal-title":"Sci Rep"},{"issue":"1","key":"6385_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/JLB.3MA0422-286R","volume":"112","author":"J de Rios los Rios","year":"2022","unstructured":"de Rios los Rios J, Enciso J, Vilchis-Ordo\u00f1ez A, V\u00e1zquez-Ram\u00edrez R, Ramirez-Ramirez D, Balandr\u00e1n JC et al (2022) Acute lymphoblastic leukemia-secreted miRNAs induce a proinflammatory microenvironment and promote the activation of hematopoietic progenitors. J Leukoc Biol 112(1):31\u201345","journal-title":"J Leukoc Biol"},{"issue":"4","key":"6385_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.eururo.2016.08.012","volume":"71","author":"M Del Re","year":"2017","unstructured":"Del Re M, Biasco E, Crucitta S, Derosa L, Rofi E, Orlandini C et al (2017) The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients. Eur Urol 71(4):680\u2013687","journal-title":"Eur Urol"},{"key":"6385_CR11","unstructured":"Diagram PF (2020) PRISMA 2020 flow diagram for new systematic reviews which included searches of databases and registers only"},{"issue":"3","key":"6385_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1515\/cclm-2024-0188","volume":"63","author":"X Dong","year":"2025","unstructured":"Dong X, Lin Y, Li K, Liang G, Huang X, Pan J, Wang L, Zhang D, Liu T, Wang T, Yan X (2025) Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine. Clin Chem Lab Med (CCLM) 63(3):465","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"1","key":"6385_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/CBM-190211","volume":"27","author":"Z Fang","year":"2020","unstructured":"Fang Z, Wang X, Wu J, Xiao R, Liu J (2020) High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia. Cancer Biomark 27(1):1\u20139","journal-title":"Cancer Biomark"},{"issue":"10","key":"6385_CR14","doi-asserted-by":"publisher","first-page":"e0141429","DOI":"10.1371\/journal.pone.0141429","volume":"10","author":"M Farahani","year":"2015","unstructured":"Farahani M, Rubbi C, Liu L, Slupsky JR, Kalakonda N (2015) CLL exosomes modulate the transcriptome and behaviour of recipient stromal cells and are selectively enriched in miR-202-3p. PLoS ONE 10(10):e0141429","journal-title":"PLoS ONE"},{"key":"6385_CR15","doi-asserted-by":"publisher","first-page":"1263834","DOI":"10.3389\/fphar.2023.1263834","volume":"14","author":"K Ghaffari","year":"2023","unstructured":"Ghaffari K, Moradi-Hasanabad A, Sobhani-Nasab A, Javaheri J, Ghasemi A (2023) Application of cell-derived exosomes in the hematological malignancies therapy. Front Pharmacol 14:1263834","journal-title":"Front Pharmacol"},{"issue":"7","key":"6385_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3324\/haematol.2017.182824","volume":"103","author":"V Giudice","year":"2018","unstructured":"Giudice V, Banaszak LG, Gutierrez-Rodrigues F, Kajigaya S, Panjwani R, Ibanez MdelPF et al (2018) Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes. Haematologica 103(7):1150","journal-title":"Haematologica"},{"issue":"1","key":"6385_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5483\/BMBRep.2022.55.1.075","volume":"55","author":"Y Hong","year":"2022","unstructured":"Hong Y, Kim IS (2022) The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer. BMB Rep 55(1):39","journal-title":"BMB Rep"},{"issue":"1","key":"6385_CR18","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1038\/srep11295","volume":"5","author":"NI Hornick","year":"2015","unstructured":"Hornick NI, Huan J, Doron B, Goloviznina NA, Lapidus J, Chang BH et al (2015) Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Rep 5(1):11295","journal-title":"Sci Rep"},{"issue":"1","key":"6385_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells13010084","volume":"13","author":"W Huang","year":"2023","unstructured":"Huang W, Paul D, Calin GA, Bayraktar R (2023) MiR-142: a master regulator in hematological malignancies and therapeutic opportunities. Cells 13(1):84","journal-title":"Cells"},{"key":"6385_CR20","unstructured":"Institute JB (2017) Checklist for case control studies: critical appraisal tools for use in JBI systematic reviews. North Adelaide, Australia"},{"key":"6385_CR21","unstructured":"Institute JB (2017) Checklist for analytical cross sectional studies, critical appraisal tools. Joanna Briggs Institute"},{"issue":"1","key":"6385_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12964-023-01102-7","volume":"21","author":"FNA Jahromi","year":"2023","unstructured":"Jahromi FNA, Dowran R, Jafari R (2023) Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment. Cell Commun Signal 21(1):88","journal-title":"Cell Commun Signal"},{"issue":"1","key":"6385_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40364-021-00272-1","volume":"9","author":"AE Jenike","year":"2021","unstructured":"Jenike AE, Halushka MK (2021) miR-21: a non-specific biomarker of all maladies. Biomark Res 9(1):18","journal-title":"Biomark Res"},{"issue":"3","key":"6385_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000491584","volume":"140","author":"L Jiang","year":"2018","unstructured":"Jiang L, Deng T, Wang D, Xiao Y (2018) Elevated serum exosomal miR-125b level as a potential marker for poor prognosis in intermediate-risk acute myeloid leukemia. Acta Haematol 140(3):183\u2013192","journal-title":"Acta Haematol"},{"issue":"11\u201312","key":"6385_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1515\/hsz-2023-0203","volume":"404","author":"S Larivera","year":"2023","unstructured":"Larivera S, Neumeier J, Meister G (2023) Post-transcriptional gene silencing in a dynamic RNP world. Biol Chem 404(11\u201312):1051\u20131067","journal-title":"Biol Chem"},{"key":"6385_CR26","doi-asserted-by":"publisher","first-page":"e51621","DOI":"10.1590\/fst.51621","volume":"42","author":"X Li","year":"2021","unstructured":"Li X, Zhang X, Ma H, Liu Y, Cheng S, Wang H et al (2021) Upregulation of serum exosomal miR-21 was associated with poor prognosis of acute myeloid leukemia patients. Food Sci Technol 42:e51621","journal-title":"Food Sci Technol"},{"issue":"10","key":"6385_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3390\/biom12101448","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Xie C, Lu Y, Chang K, Guan F, Li X (2022) Exosomal mir92a promotes cytarabine resistance in myelodysplastic syndromes by activating Wnt\/\u03b2-catenin signal pathway. Biomolecules 12(10):1448","journal-title":"Biomolecules"},{"issue":"6","key":"6385_CR28","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1039\/D2NA00959E","volume":"5","author":"L Li","year":"2023","unstructured":"Li L, Mussack V, G\u00f6rgens A, Pepeldjiyska E, Hartz AS, Aslan H et al (2023a) The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker. Nanoscale Adv 5(6):1691\u20131705","journal-title":"Nanoscale Adv"},{"issue":"1","key":"6385_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.32604\/biocell.2022.022021","volume":"47","author":"N Li","year":"2023","unstructured":"Li N, Chen X, Geng S, Lai P, Huang L, Li M, Huang X, Deng C, Wang Y, Weng J, Du X (2023b) regulates the differentiation of bone marrow mesenchymal stem cells in myelodysplastic syndrome. Biocell 47(1):133","journal-title":"Biocell"},{"issue":"2","key":"6385_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/CBM-191164","volume":"28","author":"X Lin","year":"2020","unstructured":"Lin X, Ling Q, Lv Y, Ye W, Huang J, Li X et al (2020) Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia. Cancer Biomark 28(2):151\u2013158","journal-title":"Cancer Biomark"},{"issue":"1","key":"6385_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12935-025-03772-4","volume":"25","author":"S Liu","year":"2025","unstructured":"Liu S, Wan X, Gou Y, Yang W, Xu W, Du Y et al (2025) The emerging functions and clinical implications of circRNAs in acute myeloid leukaemia. Cancer Cell Int 25(1):167","journal-title":"Cancer Cell Int"},{"issue":"17","key":"6385_CR32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F et al (2017) Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood 129(17):2429\u20132436","journal-title":"Blood"},{"issue":"12","key":"6385_CR33","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky E, Rigoutsos I (2013) The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 20(12):1603\u20131614","journal-title":"Cell Death Differ"},{"issue":"1","key":"6385_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13287-024-04125-0","volume":"16","author":"A Mohseni","year":"2025","unstructured":"Mohseni A, Salehi F, Rostami S, Hadiloo K, Hashemi M, Baridjavadi Z et al (2025) Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies. Stem Cell Res Ther 16(1):6","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"6385_CR35","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.currproblcancer.2021.100726","volume":"45","author":"M Moloudizargari","year":"2021","unstructured":"Moloudizargari M, Hekmatirad S, Mofarahe ZS, Asghari MH (2021) Exosomal microRNA panels as biomarkers for hematological malignancies. Curr Probl Cancer 45(5):100726","journal-title":"Curr Probl Cancer"},{"issue":"4","key":"6385_CR36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ijms17040570","volume":"17","author":"K Ohyashiki","year":"2016","unstructured":"Ohyashiki K, Umezu T, Katagiri S, Kobayashi C, Azuma K, Tauchi T et al (2016) Downregulation of plasma miR-215 in chronic myeloid leukemia patients with successful discontinuation of imatinib. Int J Mol Sci 17(4):570","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6385_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12015-020-10002-z","volume":"17","author":"GS Pinky","year":"2021","unstructured":"Pinky GS, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S (2021) Mesenchymal stem cell derived exosomes: a nano platform for therapeutics and drug delivery in combating COVID-19. Stem Cell Rev Rep 17(1):33\u201343","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"6385_CR38","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Andr\u00e9 F, Amigorena S, Soria JC, Eggermont A, Kroemer G et al (2016) Dendritic cell\u2013derived exosomes for cancer therapy. J Clin Invest 126(4):1224\u20131232","journal-title":"J Clin Invest"},{"key":"6385_CR39","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S131516","author":"X Qin","year":"2017","unstructured":"Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X et al (2017) Cisplatin-resistant lung cancer cell\u2013derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomed. https:\/\/doi.org\/10.2147\/IJN.S131516","journal-title":"Int J Nanomed"},{"issue":"1","key":"6385_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Feghhi M, Etemadi T (2022) A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal 20(1):145","journal-title":"Cell Commun Signal"},{"key":"6385_CR41","doi-asserted-by":"publisher","first-page":"101893","DOI":"10.1016\/j.mcp.2023.101893","volume":"67","author":"A Rzepiel","year":"2023","unstructured":"Rzepiel A, Horv\u00e1th A, Kutszegi N, G\u00e9zsi A, S\u00e1gi JC, Almasi L et al (2023) MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia. Mol Cell Probes 67:101893","journal-title":"Mol Cell Probes"},{"issue":"1","key":"6385_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41598-023-50628-w","volume":"14","author":"N Saffari","year":"2024","unstructured":"Saffari N, Rahgozar S, Faraji E, Sahin F (2024) Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia. Sci Rep 14(1):691","journal-title":"Sci Rep"},{"issue":"12","key":"6385_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/17474086.2022.2114894","volume":"15","author":"Z Shang","year":"2022","unstructured":"Shang Z, Ming X, Wu J, Liu W, Xiao Y (2022) CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p\/ALG3 axis. Expert Rev Hematol 15(12):1073\u20131083","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"6385_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/hemato3020026","volume":"3","author":"T Shibuta","year":"2022","unstructured":"Shibuta T, Shimizu H, Takada Y, Fuku A, Tomiyasu S, Umemura T (2022) miR-494 in extracellular vesicles as a potent biomarker of chronic myeloid leukemia treatment with tyrosine kinase inhibitors. Hemato 3(2):373\u2013384","journal-title":"Hemato"},{"issue":"7","key":"6385_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CJI.0000000000000179","volume":"40","author":"A Shoae-Hassani","year":"2017","unstructured":"Shoae-Hassani A, Hamidieh AA, Behfar M, Mohseni R, Mortazavi-Tabatabaei SA, Asgharzadeh S (2017) NK cell\u2013derived exosomes from NK cells previously exposed to neuroblastoma cells augment the antitumor activity of cytokine-activated NK cells. J Immunother 40(7):265\u2013276","journal-title":"J Immunother"},{"issue":"1","key":"6385_CR46","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6385_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-021-01446-z","volume":"20","author":"V Singh","year":"2021","unstructured":"Singh V, Uddin MH, Zonder JA, Azmi AS, Balasubramanian SK (2021) Circular RNAs in acute myeloid leukemia. Mol Cancer 20(1):149","journal-title":"Mol Cancer"},{"issue":"12","key":"6385_CR48","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J, W\u00fcrdinger T, Van Rijn S, Meijer DH, Gainche L, Curry WT Jr et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470\u20131476","journal-title":"Nat Cell Biol"},{"issue":"3","key":"6385_CR49","first-page":"31","volume":"27","author":"M Soleimani","year":"2024","unstructured":"Soleimani M (2024) A review of exosome-mediated immunotherapy in Iran. Pathobiol Res 27(3):31","journal-title":"Pathobiol Res"},{"key":"6385_CR50","doi-asserted-by":"publisher","first-page":"216880","DOI":"10.1016\/j.canlet.2024.216880","volume":"591","author":"H Sun","year":"2024","unstructured":"Sun H, Xie Y, Wu X, Hu W, Chen X, Wu K et al (2024) CircRNAs as prognostic markers in pediatric acute myeloid leukemia. Cancer Lett 591:216880","journal-title":"Cancer Lett"},{"issue":"8","key":"6385_CR51","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1111\/cas.13697","volume":"109","author":"Y Tai","year":"2018","unstructured":"Tai Y, Chen K, Hsieh J, Shen T (2018) Exosomes in cancer development and clinical applications. Cancer Sci 109(8):2364\u20132374","journal-title":"Cancer Sci"},{"issue":"22","key":"6385_CR52","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/onc.2012.295","volume":"32","author":"T Umezu","year":"2013","unstructured":"Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32(22):2747\u20132755","journal-title":"Oncogene"},{"key":"6385_CR53","doi-asserted-by":"publisher","first-page":"1265969","DOI":"10.3389\/fimmu.2023.1265969","volume":"14","author":"D Van Morckhoven","year":"2023","unstructured":"Van Morckhoven D, Dubois N, Bron D, Meuleman N, Lagneaux L, Stamatopoulos B (2023) Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. Front Immunol 14:1265969","journal-title":"Front Immunol"},{"issue":"4","key":"6385_CR54","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/cbin.11534","volume":"45","author":"Q Wang","year":"2021","unstructured":"Wang Q, Yu G, He H, Zheng Z, Li X, Lin R et al (2021) Differential expression of circular RNAs in bone marrow\u2010derived exosomes from essential thrombocythemia patients. Cell Biol Int 45(4):869\u2013881","journal-title":"Cell Biol Int"},{"key":"6385_CR55","doi-asserted-by":"publisher","first-page":"1033143","DOI":"10.3389\/fonc.2022.1033143","volume":"12","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Lin C, Peng M, Ren J, Jing Y, Lei L et al (2022) Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia. Front Oncol 12:1033143","journal-title":"Front Oncol"},{"issue":"5","key":"6385_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10735-025-10607-z","volume":"56","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wang Y (2025) LncRNA TMEM147-AS1 promotes acute myeloid leukemia development by regulating miR-873-3p\/ZFX axis. J Mol Histol 56(5):1\u201314","journal-title":"J Mol Histol"},{"issue":"1","key":"6385_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12967-021-03174-w","volume":"19","author":"W Yan","year":"2021","unstructured":"Yan W, Song L, Wang H, Yang W, Hu L, Yang Y (2021) Extracellular vesicles carrying miRNA-181b-5p affects the malignant progression of acute lymphoblastic leukemia. J Transl Med 19(1):511","journal-title":"J Transl Med"},{"issue":"21","key":"6385_CR58","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1182\/blood-2014-12-618470","volume":"125","author":"YY Yeh","year":"2015","unstructured":"Yeh YY, Ozer HG, Lehman AM, Maddocks K, Yu L, Johnson AJ et al (2015) Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood 125(21):3297\u20133305","journal-title":"Blood"},{"issue":"21","key":"6385_CR59","doi-asserted-by":"publisher","first-page":"30876","DOI":"10.18632\/oncotarget.9021","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Pan L, Xiang B, Zhu H, Wu Y, Chen M et al (2016) Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma. Oncotarget 7(21):30876","journal-title":"Oncotarget"},{"key":"6385_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:1\u201318","journal-title":"Cell Biosci"},{"key":"6385_CR61","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.2147\/IJN.S479697","volume":"19","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xia J, Wang X, Wang Y, Chen J, He L, Dai J (2024) Recent progress of exosomes in hematological malignancies: pathogenesis, diagnosis, and therapeutic strategies. Int J Nanomed 19:11611\u201311631","journal-title":"Int J Nanomed"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06385-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:20:49Z","timestamp":1766503249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06385-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06385-6","relation":{},"ISSN":["1432-1335"],"issn-type":[{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were carried out with the approval of the Ethics Committee of Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1404.014).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"20"}}